Page last updated: 2024-12-05

glycidyl methacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glycidyl methacrylate: RN given refers to monomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

glycidyl methacrylate : An enoate ester obtained by formal condensation of the carboxy group of methacrylic acid with the hydroxy group of glycidol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7837
CHEMBL ID1333073
CHEBI ID132844
SCHEMBL ID15617
MeSH IDM0051321

Synonyms (87)

Synonym
106-91-2
glycidyl .alpha.-methylacrylate
glycidol methacrylate
glycidyl methacrylate
nsc-24156
cp 105
methacrylic acid,3-epoxypropyl ester
wln: t3otj b1ovy1 & u1
2,3-epoxypropyl methacrylate
nsc24156
NCIOPEN2_000036
nsc-67195
nsc67195
methacrylic acid, 2,3-epoxypropyl ester
2-propenoic acid, 2-methyl-, oxiranylmethyl ester
NCGC00091055-01
blemmer gma
acriester g
2-((methacryloxy)methyl)oxirane
brn 0002506
nsc 24156
1-propanol, 2,3-epoxy-, methacrylate
2,3-epoxypropyl methacrylic acid ester
ccris 2626
light ester g
sr 379
hsdb 494
einecs 203-441-9
sy-monomer g
glycidyl alpha-methyl acrylate
glycidyl alpha-methylacrylate
blemmer g
glycidyl methacrylate, 97%, contains 100 ppm monomethyl ether hydroquinone as inhibitor
oxiran-2-ylmethyl 2-methylacrylate
(oxiran-2-yl)methyl 2-methylprop-2-enoate
CHEBI:132844
2,3-epoxypropanol methacrylate
AKOS000276065
methacrylic acid glycidyl ester
25067-05-4
M0590
STK801798
oxiran-2-ylmethyl 2-methylprop-2-enoate
oxiran-2-ylmethyl methacrylate
A801532
NCGC00091055-02
2-methyl-acrylic acid oxiran-2-yl-methyl ester
dtxsid0025361 ,
cas-106-91-2
NCGC00256974-01
dtxcid305361
tox21_303145
NCGC00259045-01
tox21_201494
BBL010914
unii-r8wn29j8vf
2-propenoic acid, 2-methyl-, 2-oxiranylmethyl ester
r8wn29j8vf ,
ec 203-441-9
5-17-03-00035 (beilstein handbook reference)
FT-0609742
glycidyl methacrylate [hsdb]
(+/-)-glycidyl methacrylate
AKOS016041668
SCHEMBL15617
2-oxiranylmethyl 2-methylacrylate #
acryester g
sr-379
2-methyl-acrylic acid oxiranylmethyl ester
glycidylmethacrylate
methacrylic acid-glycidyl ester
glycidyl-methacrylate
CHEMBL1333073
W-108764
mfcd00005137
glycidyl methacrylate, >=97.0% (gc)
glycidyl methacrylate, purum, >=97.0% (gc)
glycidyl methacrylate, (stabilized with mehq)
glycidyl methacrylate (stabilized with mehq)
glycidyl methacrylate(gma)
E75837
VS-02747
epoxypropyl methacrylate,5 cp(25 degrees c)
Q2013175
methacrylic acid glycidyl ester (stabilized with mehq)
oxiran-2-ylmethylmethacrylate
CS-0063449

Research Excerpts

Overview

Glycidyl methacrylate (GMA) is a recently recognized chemical mutagen.

ExcerptReferenceRelevance
"Glycidyl methacrylate (GMA) is a recently recognized mutagen. "( Molecular mutagenesis induced by glycidyl methacrylate.
Fang, F; Gao, H; Xie, D; Zuo, J, 1994
)
2.01
"Glycidyl methacrylate (GMA) is a recently recognized chemical mutagen. "( Analysis of the phenotype and the restriction enzyme mapping level of mutations induced by the new mutagen glycidyl methacrylate.
Fang, FD; Gao, HL; Li, ZS; Xie, DY; Yang, HF; Zhang, W; Zuo, J, 1990
)
1.93

Effects

Glycidyl methacrylate (GMA) has been widely used as tackifying/crosslinking copolymer monomer in the industrial section. It has been used as a reactive compatibilizer to improve the interface between PLA and PBAT.

ExcerptReferenceRelevance
"Glycidyl methacrylate (GMA) has been widely used as tackifying/crosslinking copolymer monomer in the industrial section. "( TMT-based quantitative proteomic analysis reveals the underlying mechanisms of glycidyl methacrylate-induced 16HBE cell malignant transformation.
Gu, Y; Jin, H; Kang, T; Li, X; Wang, M; Wang, Q; Wuhan, B; Xu, J, 2023
)
2.58
"Glycidyl methacrylate (GMA) has been used as a reactive compatibilizer to improve the interface between PLA and PBAT."( Effect of glycidyl methacrylate (GMA) on the thermal, mechanical and morphological property of biodegradable PLA/PBAT blend and its nanocomposites.
Kumar, M; Mohanty, S; Nayak, SK; Rahail Parvaiz, M, 2010
)
1.48

Toxicity

ExcerptReferenceRelevance
" The local concentration of the released monomers can be in the millimolar range, high enough to induce adverse biological effects."( Cytotoxicity and genotoxicity of glycidyl methacrylate.
Blasiak, J; Ksiazek, D; Pawlowska, E; Poplawski, T; Szczepanska, J; Wisniewska-Jarosinska, M; Wozniak, K, 2009
)
0.63

Compound-Compound Interactions

ExcerptReferenceRelevance
"Chemical modification of rubber wood (Hevea Brasiliensis) was carried out by impregnating the wood with styrene and in combination with a crosslinker Glycidyl Methacrylate (GMA)."( Chemical modification of rubber wood with styrene in combination with a crosslinker: effect on dimensional stability and strength property.
Ali, I; Devi, RR; Maji, TK, 2003
)
0.52
" The study demonstrates for the first time that derivatized cellulose particles combined with MALDI-TOF MS represent a simple, economical, and rapid approach to generate serum protein profiles for biomarker identification."( Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
Bartsch, G; Bernardo, K; Bonn, GK; Feuerstein, I; Horninger, W; Huck, CW; Klocker, H; Kofler, K; Pelzer, A; Rainer, M; Stecher, G,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" A linear dose-response relationship was observed within certain dose levels."( Formation of glycidyl methacrylate-DNA adducts in vivo.
Fang, FD; Lei, HX; Tan, MJ; Xu, JN; Zuo, J, 1999
)
0.67
" Concentrations leading to 50% cell survival (TC50 values) were calculated from fitted dose-response curves."( Responses of L929 mouse fibroblasts, primary and immortalized bovine dental papilla-derived cell lines to dental resin components.
Hiller, KA; Schmalz, G; Schweikl, H; Thonemann, B, 2002
)
0.31
" The amount of GMA-DNA adducts increased with GMA dosage within 0-125 mg/kg dosages, degree of the overall level of GMA-DNA adducts in various organs were kidney > liver > white blood cells > testis."( [Study on GMA-DNA adducts in vivo].
Lei, H; Li, Z; Tan, M; Xu, J; Zuo, J, 1999
)
0.3
" After cells were treated for 3 times, the decreases apoptosis rates and the increases of mitotic index of cell treated by high dosage were observed."( [Study on effect of glycidyl methacrylate on cell cycle and apoptosis in human bronchial epithelial cells].
Li, Y; Wang, Q; Wang, Y; Yang, M, 2007
)
0.66
" Once a day dosage forms for drugs differing in solubility have been developed using a single polymer matrix which is easy to manufacture."( pH Sensitive graft copolymers for zero order drug release: a mechanistic analysis.
Kulkarni, MG; Muthusamy, R, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency1.96810.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency67.82310.000714.592883.7951AID1259392
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency31.62280.011212.4002100.0000AID1030
progesterone receptorHomo sapiens (human)Potency27.00080.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency61.28210.003041.611522,387.1992AID1159552; AID1159553; AID1159555
activating transcription factor 6Homo sapiens (human)Potency6.10040.143427.612159.8106AID1159516
heat shock protein beta-1Homo sapiens (human)Potency59.29800.042027.378961.6448AID743210; AID743228
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (402)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (1.99)18.7374
1990's28 (6.97)18.2507
2000's112 (27.86)29.6817
2010's200 (49.75)24.3611
2020's54 (13.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 131.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index131.42 (24.57)
Research Supply Index6.02 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index243.06 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (131.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (0.73%)6.00%
Case Studies5 (1.22%)4.05%
Observational0 (0.00%)0.25%
Other401 (98.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]